In Vitro Efficacy of Flomoxef against Extended-Spectrum Beta-Lactamase-Producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> Associated with Urinary Tract Infections in Malaysia

In Vitro Efficacy of Flomoxef against Extended-Spectrum Beta-Lactamase-Producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> Associated with Urinary Tract Infections in Malaysia

The increasing prevalence of extended-spectrum β-lactamase (ESBL)-producing <i>Enterobacteriaceae</i> has greatly affected the clinical efficacy of β-lactam antibiotics in the management of urinary tract infections (UTIs). The limited treatment options have resulted in the increased use...

Full description

Bibliographic Details
Main Authors: Soo Tein Ngoi, Cindy Shuan Ju Teh, Chun Wie Chong, Kartini Abdul Jabar, Shiang Chiet Tan, Lean Huat Yu, Kin Chong Leong, Loong Hua Tee, Sazaly AbuBakar
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Antibiotics
Subjects:
antimicrobial resistance
β-lactamase inhibitor
broad-spectrum β-lactamase
resistance gene
<i>Enterobacteriaceae</i>
Online Access:https://www.mdpi.com/2079-6382/10/2/181

Similar Items

Similar Items